Description
The Ovarian Cancer Pilot Award supports innovative, high-risk/high-reward research in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. This award mechanism is designed to develop preliminary data, and innovation is an important review criterion. The goal is to encourage research aimed at extending the lives of advanced-state and recurrent patients. The maximum period of performance is 2 years, and the maximum allowable funding for the entire period of performance is $350,000 for total costs.
Key aspects of this opportunity include:
• Innovation is key, and reviewers will be blinded to the identity of the PI, collaborators, and their organization(s).
• Preliminary data are not required but are allowed.
• Applications cannot support clinical trials.
• The OCRP requires submission of a Preproposal, and full application submission is by invitation only.